Sabinsa, a global leader in science-supported nutraceuticals and cosmeceuticals ingredients, in collaboration with Organica Aromatics, developer of natural and synthetic fragrance ingredients, announce their participation in the 17th SIMPPAR International Exhibition of Raw Materials for Perfumery trade show, May 28-29, 2024 in Grasse, France.
Sabinsa emphasized the safety and efficacy of its shelf-stable LactoSpore™ Weizmannia coagulans MTCC 5856 at the technical symposium “Expanding the Lineup: Next Probiotics and Supplement” hosted by the Korean Society for Lactic Acid Bacteria and Probiotics at Seoul, Korea, last week.
Dr. Sivakumar Arumugam, Vice President, Biotechnology, Sami-Sabinsa Group, highlighted the features and applications of LactoSpore™, which has been in commercial production for over three decades. Dr. Sivakumar detailed the comprehensive safety and efficacy studies carried out on this versatile probiotic, providing the audience with valuable perspective. In his presentation, Dr. Sivakumar also outlined the different global regulatory approvals that the probiotic LactoSpore™ complies with, including the FDA GRAS, Natural Health Product in Canada by the NNHPD, TGA-Australia, and FSANZ.
High interest in shelf-stable probiotics has made LactoSpore™ a popular ingredient among functional foods and beverage manufacturers in Korea and worldwide. Unlike many other probiotic strains that require refrigeration throughout the supply chain, Weizmannia coagulans stands out due to its natural spore-forming ability and stability in ambient conditions.
For more information, visit www.sabinsa.co.kr or www.sami-sabinsagroup.com
Note: LactoSpore™, a Trademark of Sabinsa Korea Corporation.